HomeVALN • NASDAQ
add
Valneva SE
Previous close
$10.50
Day range
$10.31 - $10.60
Year range
$5.43 - $12.25
Market cap
883.02M USD
Avg Volume
19.26K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 47.69M | -9.92% |
Operating expense | 13.73M | -33.28% |
Net income | -50.02M | -35.23% |
Net profit margin | -104.89 | -50.14% |
Earnings per share | — | — |
EBITDA | -26.96M | -33.88% |
Effective tax rate | 2.08% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 109.65M | -34.84% |
Total assets | 398.84M | -20.24% |
Total liabilities | 292.67M | -8.19% |
Total equity | 106.17M | — |
Shares outstanding | 173.42M | — |
Price to book | 17.20 | — |
Return on assets | -16.34% | — |
Return on capital | -20.98% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -50.02M | -35.23% |
Cash from operations | -24.51M | -357.27% |
Cash from investing | -264.00K | -105.63% |
Cash from financing | -9.36M | -104.01% |
Net change in cash | -33.81M | -383.28% |
Free cash flow | -21.65M | -212.61% |
About
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Founded
2013
Website
Employees
700
